miRNA expression profiles in myelodysplastic syndromes reveal Epstein–Barr virus miR-BART13 dysregulation

Recently, the microRNA (miRNA) signature has been used for better characterization and understanding of the pathogenesis of different malignancies, including myelodysplastic syndromes (MDS). MDS are a heterogeneous group of stem cell disorders in which the genetic and molecular defects are not well defined. In the present study, we applied array based miRNA profiling to study 19 bone marrow cell samples of de novo MDS compared with eight healthy individuals. In addition, integration of the miRNA profiling data with our previous array comparative genomic hybridization data, from the same cohort of patients, was performed. We observed up-regulation of hsa-miR-720 and hsa-miR-21, and down-regulation of hsa-miR-671-5p and one human virus miRNA (Epstein–Barr virus miR-BART13) in MDS samples compared with normal samples. In our study, the copy number alteration harboring miRNA was not affecting miRNA expression, but a distinct microRNA expression pattern was observed, not only in MDS compared with controls, but also between MDS entities.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  A. Raza.  Hypothesis: myelodysplastic syndromes may have a viral etiology. , 1998, International journal of hematology.

[3]  A. Raza.  MYELODYSPLASTIC SYNDROMES MAY HAVE AN INFECTIOUS ETIOLOGY , 2000, Journal of toxicology and environmental health. Part A.

[4]  S. Bentley.  WHO Classification of Tumours: Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues , 2003 .

[5]  Terry Speed,et al.  Normalization of cDNA microarray data. , 2003, Methods.

[6]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[7]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[8]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[9]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[10]  Å. Borg,et al.  High Resolution Genome-Wide Array-Based Comparative Genome Hybridization Reveals Cryptic Chromosome Changes in AML and MDS Cases with Trisomy 8 as the Sole Cytogenetic Aberration. , 2005 .

[11]  J. Cigudosa,et al.  Analysis of myelodysplastic syndromes with complex karyotypes by high‐resolution comparative genomic hybridization and subtelomeric CGH array , 2005, Genes, chromosomes & cancer.

[12]  S. Pfeffer,et al.  Viruses, microRNAs and cancer , 2006, Oncogene.

[13]  Å. Borg,et al.  High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration , 2006, Leukemia.

[14]  Wessel N. van Wieringen,et al.  CGHcall: Calling aberrations for array CGH tumor profiles. , 2008 .

[15]  G. Mufti,et al.  Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes. , 2007, Blood.

[16]  G. Ehninger,et al.  The pathogenesis of myelodysplastic syndromes (MDS) , 2007 .

[17]  Gordon K. Smyth,et al.  A comparison of background correction methods for two-colour microarrays , 2007, Bioinform..

[18]  H. Deeg,et al.  Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome. , 2007, Experimental hematology.

[19]  Takuji Yamada,et al.  Association of microRNA‐34a overexpression with proliferation is cell type‐dependent , 2007, Cancer science.

[20]  E. S. Venkatraman,et al.  A faster circular binary segmentation algorithm for the analysis of array CGH data , 2007, Bioinform..

[21]  Samuel Myllykangas,et al.  CanGEM: mining gene copy number changes in cancer , 2007, Nucleic Acids Res..

[22]  M. Cazzola.  Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis , 2008, Haematologica.

[23]  P. Brousset,et al.  Myeloid Cell Differentiation Arrest by Mir-125b-1 in Myelodysplasic Syndrome and Acute Myeloid Leukemia with the T(2;11)(p21;q23) Translocation , 2008 .

[24]  Marieke E. Timmerman,et al.  Smoothing waves in array CGH tumor profiles , 2009, Bioinform..

[25]  D. Beer,et al.  MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. , 2009, Cancer research.

[26]  E. Montserrat,et al.  Hematopoiesis-related microRNA expression in myelodysplastic syndromes , 2009, Leukemia & lymphoma.

[27]  M. Loh,et al.  Accurate Detection of Uniparental Disomy and Microdeletions by SNP Array Analysis in Myelodysplastic Syndromes with Normal Cytogenetics , 2009, Leukemia.

[28]  Rafael A Irizarry,et al.  Processing of Agilent microRNA array data , 2010, BMC Research Notes.

[29]  A. Hagemeijer,et al.  Acquired mutations in TET2 are common in myelodysplastic syndromes , 2009, Nature Genetics.

[30]  S. D. Selcuklu,et al.  miR-21 as a key regulator of oncogenic processes. , 2009, Biochemical Society transactions.

[31]  J. Kutok,et al.  Coordinate Loss of a MicroRNA Mir 145 and a Protein-Coding Gene RPS14 Cooperate in the Pathogenesis of 5q- Syndrome. , 2009 .

[32]  Catarina Osório,et al.  MicroRNA expression profiling in bone marrow: Implications in hematological malignancies , 2009, Biotechnology journal.

[33]  G. Mufti,et al.  MicroRNA expression profiling of high and low risk MDS , 2009 .

[34]  D. Horsman,et al.  Array comparative genomic hybridization of peripheral blood granulocytes of patients with myelodysplastic syndrome detects karyotypic abnormalities. , 2010, American journal of clinical pathology.

[35]  H. Kreipe,et al.  Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome. , 2010, Leukemia research.

[36]  S. Knuutila,et al.  Array CGH in molecular diagnosis of mental retardation—A study of 150 Finnish patients , 2010, American journal of medical genetics. Part A.

[37]  H. Hermeking.  The miR-34 family in cancer and apoptosis , 2010, Cell Death and Differentiation.

[38]  A. Jankowska,et al.  Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations. , 2010, Leukemia research.

[39]  H. Kreipe,et al.  Aberrant microRNA expression pattern in myelodysplastic bone marrow cells. , 2010, Leukemia research.

[40]  S. Knuutila,et al.  High-resolution oligonucleotide array comparative genomic hybridization study and methylation status of the RPS14 gene in de novo myelodysplastic syndromes. , 2010, Cancer genetics and cytogenetics.

[41]  W. Hammerschmidt,et al.  Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B Cells , 2010, PLoS pathogens.

[42]  Ryan D. Morin,et al.  Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype , 2010, Nature Medicine.

[43]  G. Nucifora,et al.  Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome , 2010, Proceedings of the National Academy of Sciences.

[44]  B. Ebert,et al.  The genetic basis of myelodysplastic syndromes. , 2010, Hematology/oncology clinics of North America.

[45]  H. Votavova,et al.  Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome , 2011, European Journal of Human Genetics.

[46]  S. Knuutila,et al.  MicroRNA microarrays on archive bone marrow core biopsies of leukemias--method validation. , 2011, Leukemia research.